Telmisartan Dispersible Tablets Market to Witness Astonishing Growth by 2029
Telmisartan dispersible tablets market is anticipated to grow at a CAGR of 3.2% during the forecast period. Telmisartan dispersible tablets are the type of medications used to treat high blood pressure (hypertension). Telmisartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so blood can flow more easily. The rising incidence of hypertension globally is the major factor accelerating the growth of the global telmisartan dispersible tablets market. In addition, rising expenditure on health, an increase in cardiovascular diseases, and growing tobacco users are fueling the growth of the market.
According to WHO (World Health
Organization), more than 1.13 billion people are suffering from hypertension globally,
among them, only 1 in each 5 is cured or under control. Among global mortality
cases records, hypertension shares 12.8% of all, which means 7.5 billion
mortality cases are recorded due to high blood pressure or hypertension.
However, the market growth can be hampered by the lack of awareness regarding
the use of antihypertensive drugs such as telmisartan dispersible tablets among
the population living in rural areas. Apart from these, the introduction of
novel drug/therapeutic compounds with disease-modifying capabilities and better
effectiveness by major players can bring new growth opportunities to the market
during the forecast period.
To Request a Sample of our Report on Telmisartan Dispersible
Tablets Market: https://www.omrglobal.com/request-sample/telmisartan-dispersible-tablets-market
Telmisartan Dispersible Tablets Market
Segmentation
By Product Type
·
80 mg
·
40 mg
By Distribution
Channel
·
Online Sales
·
Offline Sales
A
full Report of Telmisartan Dispersible
Tablets Market is Available @ https://www.omrglobal.com/industry-reports/telmisartan-dispersible-tablets-market
North America
· United
States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest
of Europe
Asia-Pacific
· India
· China
· Japan
· South
Korea
· Rest
of APAC
Rest of the World
Company Profiles
·
Abbott Laboratories
·
Astellas Pharma Inc.
·
Bayer AG
·
Beijing Wansheng Pharmaceutical
·
Boehringer Ingelheim Ltd.
·
Dr. Reddy’s Laboratories Ltd
·
GSK Plc
·
Hema Pharmaceuticals Pvt. Ltd.
·
Mylan N.V.
·
Novartis AG
·
Pfizer, Inc.
·
Takeda Pharmaceutical Co. Ltd.
·
Teva Pharmaceutical Industries Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data,
Request for Report Customization @ https://www.omrglobal.com/report-customization/telmisartan-dispersible-tablets-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment